IMAC Holdings, Inc. (NASDAQ:IMAC – Get Free Report)’s stock price traded up 35.5% during mid-day trading on Tuesday . The company traded as high as $4.79 and last traded at $4.54. 951,671 shares traded hands during mid-day trading, an increase of 34% from the average session volume of 708,132 shares. The stock had previously closed at $3.35.
IMAC Price Performance
The firm’s 50 day moving average price is $2.01 and its two-hundred day moving average price is $1.95. The company has a debt-to-equity ratio of 0.01, a current ratio of 1.27 and a quick ratio of 1.27.
Institutional Investors Weigh In On IMAC
An institutional investor recently bought a new position in IMAC stock. State Street Corp purchased a new position in IMAC Holdings, Inc. (NASDAQ:IMAC – Free Report) during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor purchased 40,161 shares of the company’s stock, valued at approximately $33,000. State Street Corp owned about 0.15% of IMAC at the end of the most recent reporting period. Institutional investors own 24.27% of the company’s stock.
IMAC Company Profile
IMAC Holdings, Inc owns, manages, and subleases a chain of innovative medical advancements and care regeneration centers in the United States. The company's outpatient medical clinics provide regenerative, orthopedic, and minimally invasive procedures and therapies to patients with sports injuries, ligament and tendon damage, and other related soft tissue conditions, as well as back, knee, and joint pains.
Recommended Stories
- Five stocks we like better than IMAC
- What is Forex and How Does it Work?
- Silicon Motion Proves That AI in Motion Stays in Motion
- How to Invest in Blue Chip Stocks
- Undervalued UnitedHealth Group Won’t Be For Long
- How to Effectively Use the MarketBeat Ratings Screener
- The 5 Stocks Most Sold By Insiders This Year
Receive News & Ratings for IMAC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IMAC and related companies with MarketBeat.com's FREE daily email newsletter.